pepticrad-1
Showing 1 - 1 of 1
Melanoma (Skin), Triple-Negative Breast Cancer, NSCLC Trial (PeptiCRAd-1, Cyclophosphamide, Pembrolizumab)
Not yet recruiting
- Melanoma (Skin)
- +2 more
- PeptiCRAd-1
- +2 more
- (no location specified)
Aug 5, 2022